Insight Wealth Strategies, LLC Bristol Myers Squibb CO Transaction History

Insight Wealth Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $409,844 - $446,320	-6,620 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $4,391 - $4,938	74 Added 1.13%	6,620 $418,000
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $48,097 - $54,503	-833 Reduced 11.29%	6,546 $406,000
Q3 2020 Oct 29, 2020	BUY	$57.43 - $63.64 $423,775 - $469,599	7,379 New	7,379 $445,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Insight Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Wealth Strategies, LLC with notifications on news.